Clinical Trial Update: Canadian Ticagrelor Survey

View source ↗

Summary

AstraZeneca reports completion of a Canadian ticagrelor survey trial related to Acute Coronary Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Acute Coronary Syndrome | Status: COMPLETED